Kailera director granted 38,300 stock options
Kailera Therapeutics, Inc. director Frank Clyburn received a grant of stock options on April 16, 2026.
Rhea-AI Filing Summary
Kailera Therapeutics, Inc. director Frank Clyburn received a grant of stock options on April 16, 2026. The award covers 38,300 options to buy common stock at an exercise price of $16.00 per share, all held as direct ownership.
Following this grant, Clyburn holds 38,300 stock options. According to the terms, the options vest and become exercisable for 100% of the underlying shares on April 16, 2027, provided he continues to serve the company through that vesting date. The options are scheduled to expire on April 16, 2036 if not exercised.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 38,300 shares
Grant/Award
1 txn
Insider
Clyburn Frank
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 38,300 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 38,300 contracts (Direct)
Footnotes (1)
- F1. The options vest and become exercisable as to 100% of the underlying shares on April 16, 2027, subject to the Reporting Person's continued service through each such vesting date.
Key Figures
Options granted: 38,300 options
Exercise price: $16.00 per share
Underlying shares: 38,300 shares
+3 more
6 metrics
Options granted
38,300 options
Stock option grant to director on April 16, 2026
Exercise price
$16.00 per share
Strike price for the 38,300 stock options
Underlying shares
38,300 shares
Common stock underlying the granted options
Post-grant derivative holdings
38,300 options
Total stock options held after transaction
Vesting date
April 16, 2027
Date when 100% of options vest, subject to service
Expiration date
April 16, 2036
Scheduled expiration of the stock options
Key Terms
Stock Option (right to buy), exercise price, vesting, underlying shares, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: "Stock Option (right to buy)""
exercise price financial
"conversion_or_exercise_price: "16.0000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The options vest and become exercisable as to 100% of the underlying shares"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: "2036-04-16T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Kailera Therapeutics (KLRA) report for Frank Clyburn?
Kailera Therapeutics reported that director Frank Clyburn received a grant of 38,300 stock options. These options give him the right to buy common shares at $16.00 per share, subject to vesting and future exercise conditions set by the company.
How many Kailera Therapeutics (KLRA) stock options were granted to Frank Clyburn?
Frank Clyburn was granted 38,300 stock options. Each option relates to one share of Kailera Therapeutics common stock, so the grant covers 38,300 underlying shares, all held as direct ownership after the reported transaction.
What is the exercise price and expiration date of Frank Clyburn’s KLRA stock options?
The granted stock options have an exercise price of $16.00 per share and are scheduled to expire on April 16, 2036. This means he can choose to exercise them at $16.00 any time after vesting and before that expiration date.
When do Frank Clyburn’s Kailera Therapeutics stock options vest?
The options vest and become exercisable as to 100% of the underlying 38,300 shares on April 16, 2027. Vesting is conditioned on Clyburn’s continued service with Kailera Therapeutics through that vesting date, according to the disclosed footnote terms.
Is Frank Clyburn’s KLRA option grant an open-market purchase or compensation award?
The filing classifies the transaction as a grant or award acquisition, not an open-market purchase. The options were awarded at a $16.00 exercise price and carry vesting conditions, which is typical of equity-based director or executive compensation programs.
AI-generated analysis. How Rhea-AI works. Not financial advice.
